<keyword id="15862275" type="General" weightage="20" keywordseo="Bharat-Biotechs-intranasal-Covid-vaccine" source="Orion">Bharat Biotech's intranasal Covid vaccine</keyword> has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening, they said. The <keyword id="383216" type="General" weightage="20" keywordseo="nasal-vaccine" source="Orion">nasal vaccine</keyword> -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose. The approval for the vaccine comes amid a spurt in <keyword id="8764262" type="General" weightage="100" keywordseo="covid" source="Orion">Covid</keyword> cases in China and some other countries. Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged them to wear masks in crowded places, while also directing officials to strengthen surveillance measures, especially at international airports. SEE ALSO: <a href="https://www.businessinsider.in/international/news/police-officers-were-seen-guarding-a-crematorium-in-beijing-amid-reports-of-overflowing-funeral-homes-due-to-a-resurgence-in-covid-infections-bloomberg/articleshow/96369408.cms">Police officers were seen guarding a crematorium in Beijing amid reports of overflowing funeral homes due to a resurgence in COVID infections: Bloomberg</a> <a href="https://www.businessinsider.in/india/news/pm-modi-to-review-covid-19-situation-at-high-level-meeting-today/articleshow/96417240.cms">PM Modi to review Covid-19 situation at high-level meeting today</a> <a href="https://www.businessinsider.in/science/health/3-cases-of-omicron-subvariant-bf-7-driving-chinas-covid-surge-detected-in-india/articleshow/96397261.cms">3 cases of Omicron subvariant BF.7, driving China's Covid surge, detected in India</a>

Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN

<ul><li>Bharat Biotech's <keyword id="10629438" type="General" weightage="20" keywordseo="intranasal-covid-vaccine" source="Orion">intranasal Covid vaccine</keyword> is now available on <keyword id="10440405" type="General" weightage="20" keywordseo="cowin" source="Orion">CoWin</keyword>.</li><li>People who have taken both doses of Covid vaccine are eligible for a nasal <keyword id="2825536" type="General" weightage="20" keywordseo="booster-dose" source="Orion">booster dose</keyword>.</li><li>The nasal Covid vaccine will be available for people aged 18 and above.</li></ul>With the surge in Covid-19 cases globally, and this time the BF.7 variant that is said to be highly transmissible and has a shorter incubation period, the Government of India has approved the use of the world’s first needless jab Incovacc, developed by Bharat Biotech. The nasal vaccine will be available for people aged 18 and above. It can be administered as a precautionary dose to adults who have taken the two doses of either Covishield or Covaxin. The nasal vaccine Incovacc will cost ₹800 + 5 percent GST + hospital charges per dose in any private hospital. For the government hospital, the vaccine is said to be priced at ₹325. <cmsannotation type="cmsannotation" annotationid="How to book for Covid nasal vaccine online" comment="subhead" text="How to book for Covid nasal vaccine online">How to book for Covid nasal vaccine online</cmsannotation> To book a nasal vaccine online, visit the CoWin portal <a href="https://www.cowin.gov.in/">here</a> and follow the given instructions below. <ol><li>Login with your registered mobile number.</li><li>Enter OTP to verify.</li><li>Once logged in, click on your vaccine status and tap on the available booster dose. Note that you are eligible for a booster dose only if you have taken a second dose of the vaccine</li><li>Enter the district name or pin code to search for the nearest vaccination center.</li><li>Select your preferred center, date, and time.</li><li>Once selected, confirm your slot.</li><li>Also, once you take the jab, you can download and save the vaccination certificate for further use.</li></ol>Following the approval of the nasal vaccine online, developer Bharat Biotech has listed the advantages of the nasal vaccine Incovacc. Bharat Biotech said it is great for people afraid of needles since the vaccination process is needle-free and non-invasive. The company also said the nasal route has excellent potential for vaccination due to well organized immune system of the nasal mucosa. Further, the nasal vaccine also eliminates the risk of infections associated with needles. At last, due to the simplicity of the delivery mechanism, the nasal vaccine Incovacc does not require trained healthcare workers. SEE ALSO: <a href="https://www.businessinsider.in/tech/news/iphone-15-to-reality-pro-vr-headset-check-out-the-list-of-upcoming-apple-products-in-2023/articleshow/96448076.cms">iPhone 15 to Reality Pro VR headset — check out the list of upcoming Apple products in 2023</a> <a href="https://www.businessinsider.in/tech/apps/news/this-app-wants-to-pay-you-to-share-your-data-for-advertising/articleshow/96418063.cms">This app wants to pay you to share your data for advertising</a>

Covid-19 Nasal vaccine is available on the CoWin portal — here’s how to book your dose

<keyword id="3658" type="General" weightage="100" keywordseo="india" source="Orion">India</keyword>'s first intranasal <keyword id="8764262" type="General" weightage="80" keywordseo="covid" source="Orion">Covid</keyword> vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.Announcing the achievements, Union Health Minister Mansukh <keyword id="337625" type="General" weightage="50" keywordseo="mandaviya" source="Orion">Mandaviya</keyword> termed it a 'big boost to India's fight against Covid-19. "Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation," Mandaviya tweeted. In the subsequent tweet he said, "This step will further strengthen our collective fight against the pandemic." India has harnessed its science, R&amp;D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership. With the science-driven approach &amp; <keyword id="11898291" type="General" weightage="50" keywordseo="sabka-prayas" source="Orion">Sabka Prayas</keyword>, we will defeat COVID-19", he said. SEE ALSO : <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/dreamfolks-services-beats-grey-market-expectations-lists-at-a-55-premium/articleshow/94017839.cms">DreamFolks Services stock slips 8% from its listing price</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/green-buildings-command-rental-premiums-of-13-36-as-demand-grows-jll/articleshow/94030867.cms">Green buildings command rental premiums of 13-36% as demand grows: JLL</a>

India's first intranasal Covid vaccine gets DCGI nod for restricted use

New Delhi, Mar 9 ( PTI) The AIIMS will start the booster dose trial of Bharat Biotech's intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at least five months ago but not more than seven months back, Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS, New Delhi told PTI. India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The Drugs Controller General of India (DCGI) in January had given permission to Bharat Biotech to conduct phase-3 randomized, multi-centric study to evaluate the immunogenicity and safety of the booster dose in participants previously vaccinated with Covishield or Covaxin. "We got the ethical approval for initiating the booster dose trial on Wednesday. Registration for the participants will start from March 10 via email --HYPERLINK "mailto:ctaiims.covid19@gmail.com"ctaiims.covid19@gmail.com --- and whatsapp (7428847499) for those who received both the doses of either Covaxin or Covishield more than 5 months but less than 7 months ago," Dr Rai said. AIIMS, New Delhi is one among the five sites where the booster trial for the nasal vaccine will be conducted. BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. PTI PLB CK

AIIMS Delhi to start booster dose trial of intranasal Covid vaccine from Friday

<ul><li>The targeted reporters were Emily Baker-White, who wrote for BuzzFeed and is now at Forbes, and <keyword id="15863221" type="General" weightage="50" keywordseo="cristina-criddle" source="Orion">Cristina Criddle</keyword> of the <keyword id="35662" type="General" weightage="50" keywordseo="financial-times" source="Orion">Financial Times</keyword>.</li><li><keyword id="3749909" type="General" weightage="80" keywordseo="bytedance" source="Orion">ByteDance</keyword> said it had restructured its internal audit and risk team and had removed any access to US data from that department.</li><li>The investigation was initiated after an article was published by Forbes, and the inquiry confirms part of that report.</li></ul> ByteDance, the Chinese parent company of <keyword id="6762469" type="General" weightage="100" keywordseo="tiktok" source="Orion">TikTok</keyword>, said on Thursday that an internal investigation found that employees had inappropriately obtained the data of US TikTok users, including that of two US reporters, according to an email seen by Reuters. The targeted reporters were Emily Baker-White, who wrote for BuzzFeed and is now at Forbes, and Cristina Criddle of the Financial Times, ByteDance said, though it declined to identify other affected TikTok users. ByteDance employees accessed the data as part of an unsuccessful effort to investigate leaks of company information and were aiming to identify potential connections between two journalists and company employees, revealed the email from ByteDance general counsel <keyword id="15860720" type="General" weightage="50" keywordseo="erich-andersen" source="Orion">Erich Andersen</keyword>. All four employees involved in the scheme were fired, the company said, correcting an earlier statement that one of the four had resigned. Two of those employees were working in China and two were in the United States, reported The <keyword id="53556" type="General" weightage="50" keywordseo="new-york-times" source="Orion">New York Times</keyword>. ByteDance said it had restructured its internal audit and risk team and had removed any access to US data from that department. Over the summer, a few employees on a ByteDance team responsible for monitoring employee conduct tried to find the sources of suspected leaks of internal conversations and business documents to journalists. In doing so, the employees gained access to the IP addresses and other data of two reporters and a small number of people connected to the reporters via their TikTok accounts. They were trying to determine if those individuals were within proximity of ByteDance employees, according to the company, which added that the efforts failed to find any leaks, reported The New York Times. The investigation was initiated after an article was published by Forbes, and the inquiry confirms part of that report and highlights the privacy and security risks associated with TikTok that US lawmakers, state governors and the <keyword id="6354862" type="General" weightage="50" keywordseo="trump" source="Orion">Trump</keyword> and <keyword id="60973" type="General" weightage="50" keywordseo="biden" source="Orion">Biden</keyword> administrations have raised for more than two years. More than a dozen states have banned TikTok from government-issued devices, and the company has been in prolonged negotiations with the administration on security and privacy measures that would block any potential access of US user data by ByteDance and the Chinese government, reported NYT. Taiwan is investigating Douyin International, the Chinese twin of hugely popular TikTok, for allegedly illegally expanding social media business in the island nation, reported Voice of America (VOA). On Monday (December 19), the Mainland Affairs Council of the Executive Yuan, confirmed in a local media report the allegations made by a political affairs member of the Executive Yuan that the Mainland Affairs Council took note of the Chinese company ByteDance's opening of a branch in Taiwan, further accusing it of business expansion and transferring cases involving related operators to criminal offences to the judicial authorities for investigation. App developer ByteDance, headquartered in Beijing, was suspected of running a subsidiary in contravention of a law that restricts a variety of Chinese firms, including social media companies, from operating offices in Taiwan. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/health/news/bharat-biotechs-intranasal-covid-vaccine-approved-by-govt-to-be-available-on-co-win/articleshow/96444958.cms">Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/cash-logistics-company-radiant-cash-management-raises-116-crore-from-anchor-investors/articleshow/96445146.cms">Cash-logistics company Radiant Cash Management raises ₹116 crore from anchor investors</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/careers/news/over-half-of-the-employees-in-india-bored-with-their-current-jobs-indeed/articleshow/96428913.cms">Over half of the employees in India bored with their current jobs: Indeed</a>

You Searched For "intranasal Covid vaccine" and got 5 results

Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN

PTI

Covid-19 Nasal vaccine is available on the CoWin portal — here’s how to book your dose

Rahul Verma

India's first intranasal Covid vaccine gets DCGI nod for restricted use

IANS

AIIMS Delhi to start booster dose trial of intranasal Covid vaccine from Friday

PTI

TikTok employees spied on US journalists

ANI